Beaumont A, O'Donohue M J, Paredes N, Rousselet N, Assicot M, Bohuon C, Fournié-Zaluski M C, Roques B P
Département de Pharmacochimie Moléculaire et Structurale, Université René Descartes, Faculté de Pharmacie, Paris, France.
J Biol Chem. 1995 Jul 14;270(28):16803-8. doi: 10.1074/jbc.270.28.16803.
In the zinc metallopeptidases produced by the genus Bacillus, an active site histidine has been proposed to either stabilize the transition state in catalysis by donating a hydrogen bond to the hydrated peptide (Matthews, B. W. (1988) Acc. Chem. Res. 21, 333-340) or to polarize a water molecule, which subsequently attacks the peptidyl bond (Mock, W. L., and Aksamawati, M. (1994) Biochem. J. 302, 57-68). Site-directed mutagenesis techniques have been used to change this residue in the zinc endopeptidase from Bacillus stearothermophillus to either phenylalanine or alanine. At pH 7.0, the kcat/Km values of the substrate leucine enkephalin for the phenylalanine and alanine mutants were reduced by factors of 430- and 500-fold, respectively, as compared with the wild-type enzyme, mostly due to changes in kcat. In addition, the enzymatic activities of the mutant enzymes showed little pH dependence in the alkaline range, unlike the wild-type enzyme. The mutations did not greatly alter the binding affinities of inhibitors containing sulfydryl groups to chelate the active site zinc, while those of inhibitors containing hydroxamate or carboxylate zinc-chelating groups were increased between 80- and 250-fold. The largest change in the binding affinity of an inhibitor (> 5 orders of magnitude) was found with the proposed transition state mimic, phosphoramidon. The results are generally in agreement with x-ray crystallography studies and favor the involvement of the active site histidine in transition state binding.
在芽孢杆菌属产生的锌金属肽酶中,有人提出活性位点组氨酸要么通过向水合肽提供氢键来稳定催化过程中的过渡态(马修斯,B.W.(1988年)《化学研究述评》21卷,333 - 340页),要么使水分子极化,随后水分子攻击肽键(莫克,W.L.和阿克萨马瓦蒂,M.(1994年)《生物化学杂志》302卷,57 - 68页)。定点诱变技术已被用于将嗜热脂肪芽孢杆菌锌内肽酶中的这个残基替换为苯丙氨酸或丙氨酸。在pH 7.0时,与野生型酶相比,苯丙氨酸和丙氨酸突变体对底物亮氨酸脑啡肽的kcat/Km值分别降低了430倍和500倍,这主要是由于kcat的变化。此外,与野生型酶不同,突变酶的酶活性在碱性范围内几乎没有pH依赖性。这些突变并没有显著改变含有巯基以螯合活性位点锌的抑制剂的结合亲和力,而含有异羟肟酸酯或羧酸盐锌螯合基团的抑制剂的结合亲和力增加了80至250倍。在所提出的过渡态类似物磷酰胺脒中发现抑制剂的结合亲和力变化最大(超过5个数量级)。结果总体上与X射线晶体学研究一致,支持活性位点组氨酸参与过渡态结合。